Table 5.
Association of VEGF haplotypes with breast cancer risk in pre menopausal and post menopausal patients
| Haplotypea | Pre menopausal (%) n = 114 |
Post menopausal (%) n = 129 |
OR (95%CI) | p value |
|---|---|---|---|---|
| AICGCC | 29.0 | 31.9 | 1 (Reference) | |
| CDTCCC | 20.6 | 24.8 | 0.95 (0.54–1.67) | 0.86 |
| CDTGCC | 25.0 | 17.6 | 1.42 (0.82–2.47) | 0.22 |
| AICGTC | 9.0 | 9.2 | 1.05 (0.48–2.33) | 0.90 |
| AICGCT | 3.1 | 3.3 | 0.70 (0.12–3.90) | 0.68 |
| CDTCCT | 3.8 | 1.1 | 3.01 (0.55–16.65) | 0.21 |
| AITGTC | 2.8 | 1.8 | 0.24 (0.03–1.97) | 0.18 |
| AITGCC | 1.5 | 1.2 | 1.31 (0.29–5.96) | 0.73 |
OR odds ratio, CI confidence interval
aIn order of −2578C/A, −2549I/D, −460T/C, +405C/G, −7C/T and +936C/T